Physician profile
Nichelle E Jensen
NPI 1205287612
$8,689.52
in general payments reported to CMS, 2019-2025
11 companies · $1,200 in 2025
The $1,200 reported for 2025 was more than what 88% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,238 · 2022: $1,926 · 2023: $2,900 · 2024: $1,426 · 2025: $1,200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,140 · Travel and Lodging: $1,385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,140.32 |
| Travel and Lodging | $1,385.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,905.06 | 2021-2025 | Watchman Access System, Watchman Flx, Watchman |
| Edwards Lifesciences Corporation | $1,180.71 | 2021-2025 | Sapien 3 Ultra Resilia |
| Biosense Webster, INC. | $696.89 | 2021-2025 | Carto 3, Qdot Micro Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $377.34 | 2021-2024 | Lifevest |
| Abbott Laboratories | $304.88 | 2021-2024 | Cardiomems, Aveir, Thoratec Heartmate 3 Lvas Implant Kit |
| Astrazeneca Pharmaceuticals LP | $90.00 | 2021 | |
| Amgen INC. | $55.73 | 2021-2022 | |
| Medtronic, INC. | $36.64 | 2023 | Corevalve Evolut R |
| Cvrx, INC. | $16.07 | 2024 | Barostim Neo System |
| Mindray Ds USA, INC. | $14.77 | 2025 | Patient Monitor, Na Electrode,Indirect,International |
| Abbvie INC. | $11.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nichelle Jensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.